Teva Wants AstraZeneca's Diabetes Drug Patent Revoked
Generics giant Teva has asked a London court to ax AstraZeneca's expired patent and soon-to-expire supplementary protection certificates for a diabetes drug, arguing the medication never merited protection....To view the full article, register now.
Already a subscriber? Click here to view full article